Mylan’s Bid to Buy Perrigo Is Complicated by Opposing Declarations

Friday, August 14, 2015 - 17:50 in Mathematics & Economics

I.S.S., an influential advisory firm, recommends that investors vote down the drug maker’s pursuit, but a hedge fund with a stake in Mylan supports the merger.

Read the whole article on NY Times Science

More from NY Times Science

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net